Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,362.61
    +2,947.18 (+6.22%)
     
  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

New Strong Sell Stocks for October 14th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Adecco AHEXY offers a wide variety of services that connects colleagues with clients every day. The Zacks Consensus Estimate for its current year earnings has been revised 9.1% downward over the last 60 days.

Bellway BLWYY is engaged in building of residential houses and conduct associated trading activities. The Zacks Consensus Estimate for its current year earnings has been revised almost 18.0% downward over the last 60 days.

Catalent CTLT is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs, protein, cell, and gene therapy biologics, and consumer health products. The Zacks Consensus Estimate for its current year earnings has been revised 10.7% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Adecco SA (AHEXY) : Free Stock Analysis Report
 
Catalent, Inc. (CTLT) : Free Stock Analysis Report
 
Bellway (BLWYY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research